Engineering the vasculature for islet transplantation
Source abstract
Abstract
The microvasculature in the pancreatic islet is highly specialized for glucose sensing and insulin secretion. Although pancreatic islet transplantation is a potentially life-changing treatment for patients with insulin-dependent diabetes, a lack of blood perfusion reduces viability and function of newly transplanted tissues. Functional vasculature around an implant is not only necessary for the supply of oxygen and nutrients but also required for rapid insulin release kinetics and removal of metabolic waste. Inadequate vascularization is particularly a challenge in islet encapsulation. Selectively permeable membranes increase the barrier to diffusion and often elicit a foreign body reaction including a fibrotic capsule that is not well vascularized. Therefore, approaches that aid in the rapid formation of a mature and robust vasculature in close proximity to the transplanted cells are crucial for successful islet transplantation or other cellular therapies. In this paper, we review various strategies to engineer vasculature for islet transplantation. We consider properties of materials (both synthetic and naturally derived), prevascularization, local release of proangiogenic factors, and co-transplantation of vascular cells that have all been harnessed to increase vasculature. We then discuss the various other challenges in engineering mature, long-term functional and clinically viable vasculature as well as some emerging technologies developed to address them. The benefits of physiological glucose control for patients and the healthcare system demand vigorous pursuit of solutions to cell transplant challenges. STATEMENT OF SIGNIFICANCE: Insulin-dependent diabetes affects more than 1.25 million people in the United States alone. Pancreatic islets secrete insulin and other endocrine hormones that control glucose to normal levels. During preparation for transplantation, the specialized islet blood vessel supply is lost. Furthermore, in the case of cell encapsulation, cells are protected within a device, further limiting delivery of nutrients and absorption of hormones. To overcome these issues, this review considers methods to rapidly vascularize sites and implants through material properties, pre-vascularization, delivery of growth factors, or co-transplantation of vessel supporting cells. Other challenges and emerging technologies are also discussed. Proper vascular growth is a significant component of successful islet transplantation, a treatment that can provide life-changing benefits to patients.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Pancreatic function and diabetes · 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Endothelial cell functions10.1002/jcp.10333 ↗
2. Mechanisms of angiogenesis and arteriogenesis10.1038/74651 ↗
3. Vasculogenesis and its cellular therapeutic applications10.1159/000448551 ↗
4. Arteriogenesis: the development and growth of collateral arteries10.1080/mic.10.1.83.97 ↗
5. Alberts · 2002
6. Vascularization in tissue engineering10.1016/j.tibtech.2008.04.009 ↗
7. Engineering vascularized skeletal muscle tissue10.1038/nbt1109 ↗
8. Harnessing sphingosine-1-phosphate signaling and nanotopographical cues to regulate skeletal muscle maturation and vascularization10.1021/acsnano.7b00186 ↗
9. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue10.1073/pnas.0908381106 ↗
10. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome10.1073/pnas.0812242106 ↗
11. Transplantation of a tissue-engineered human vascularized cardiac muscle10.1089/ten.tea.2009.0130 ↗
12. Vascularized organoid engineered by modular assembly enables blood perfusion10.1073/pnas.0602740103 ↗
13. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct10.1089/ten.2006.12.2685 ↗
14. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds10.1016/j.biomaterials.2008.09.058 ↗
15. Induced neuro-vascular interactions robustly enhance functional attributes of engineered neural implants10.1016/j.biomaterials.2018.07.001 ↗
16. A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute10.1089/ten.tea.2010.0189 ↗
17. Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived cells10.1016/j.biomaterials.2014.02.049 ↗
18. Cell sheet engineering using the stromal vascular fraction of adipose tissue as a vascularization strategy10.1016/j.actbio.2017.03.034 ↗
19. Bioprinting of a functional vascularized mouse thyroid gland construct10.1088/1758-5090/aa7fdd ↗
20. Staged in vitro reconstitution and implantation of engineered rat kidney tissue10.1073/pnas.0710428105 ↗
21. Biomimetic hydrogels with pro-angiogenic properties10.1016/j.biomaterials.2010.01.104 ↗
22. The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes10.4161/isl.2.4.12156 ↗
23. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature10.1152/ajpheart.00133.2005 ↗
24. Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo10.1152/ajpendo.00715.2009 ↗
25. Cell polarity defines three distinct domains in pancreatic beta-cells
26. The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation10.1016/j.devcel.2006.01.015 ↗
27. Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse pancreatic islets10.1172/JCI36209 ↗
28. Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes10.1172/JCI114574 ↗
29. Orientation of microvascular blood flow in pancreatic islet isografts10.1172/JCI117228 ↗
30. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function10.1073/pnas.0510790103 ↗
31. Pancreatic islet blood flow and its measurement10.3109/03009734.2016.1164769 ↗
32. Portal circulations and their relation to counter-current systems
33. A comparative study of the portal vessels connecting the endocrine and exocrine pancreas, with a discussion of some functional implications
34. Islet microvasculature alterations with loss of Beta-cells in patients with type 1 diabetes
35. Pancreatic islet plasticity Interspecies comparison of islet architecture and composition10.4161/isl.2.3.11815 ↗
36. Human islet morphology revisited: human and rodent islets are not so different after all10.1369/0022155415570969 ↗
37. Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models10.1038/s41467-018-03953-y ↗
38. Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets
39. Angiogenic capacity of endothelial cells in islets of Langerhans10.1096/fj.02-0615fje ↗
40. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts10.2337/diabetes.54.8.2287 ↗
41. Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets10.1073/pnas.1619216114 ↗
42. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets10.2337/diabetes.53.5.1318 ↗
43. Better vascular engraftment and function in pancreatic islets transplanted without prior culture10.1007/s00125-004-1650-x ↗
44. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice10.1038/35024089 ↗
45. FDA regulation of stem-cell-based therapies10.1056/NEJMhpr063086 ↗
46. Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes10.1073/pnas.1708420114 ↗
47. The regulation of pancreatic islet blood flow10.1002/dmr.5610100405 ↗
48. Islet encapsulation10.1039/C8TB02020E ↗
49. Characterization of a nanogland for the autotransplantation of human pancreatic islets10.1039/c3lc50601k ↗
50. Nanoporous immunoprotective device for stem-cell-derived beta-cell replacement therapy10.1021/acsnano.7b01239 ↗
51. Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells10.1016/j.biomaterials.2018.05.047 ↗
52. Advances in local drug release and scaffolding design to enhance cell therapy for diabetes10.1089/ten.teb.2015.0275 ↗
53. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans10.2337/diab.38.1.S199 ↗
54. Time course and quantification of pancreatic islet revascularization following intraportal transplantation10.3727/000000007783464993 ↗
55. Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin10.1038/srep15521 ↗
56. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function10.2337/diab.45.9.1161 ↗
57. Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice10.2337/diab.44.1.104 ↗
58. Neovascularization of synthetic membranes directed by membrane microarchitecture10.1002/jbm.820291208 ↗
59. A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells10.1016/j.biomaterials.2013.09.071 ↗
60. Time course of membrane microarchitecture-driven neovascularization10.1016/0142-9612(96)85565-7 ↗
61. Exogenous pro-angiogenic stimuli cannot prevent physiologic vessel regression10.1016/j.jss.2006.04.006 ↗
62. Live imaging of wound angiogenesis reveals macrophage orchestrated vessel sprouting and regression10.15252/embj.201797786 ↗
63. The effect of pore size on tissue ingrowth and neovascularization in porous bioceramics of controlled architecture in vivo10.1088/1748-6041/6/1/015007 ↗
64. Neovascularization in biodegradable inverse opal scaffolds with uniform and precisely controlled pore sizes10.1002/adhm.201200106 ↗
65. The role of pore size on vascularization and tissue remodeling in PEG hydrogels10.1016/j.biomaterials.2011.04.066 ↗
66. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy10.1002/jbm.a.20016 ↗
67. Comparative effects of scaffold pore size, pore volume, and total void volume on cranial bone healing patterns using microsphere-based scaffolds10.1002/jbm.a.32015 ↗
68. Proangiogenic scaffolds as functional templates for cardiac tissue engineering10.1073/pnas.1006442107 ↗
69. Nanofibrous peptide hydrogel elicits angiogenesis and neurogenesis without drugs, proteins, or cells10.1016/j.biomaterials.2018.01.033 ↗
70. Injectable and inherently vascularizing semi-interpenetrating polymer network for delivering cells to the subcutaneous space10.1016/j.biomaterials.2017.03.032 ↗
71. Reactive capsule formation around soft-tissue implants is related to cell necrosis10.1002/(SICI)1097-4636(19990915)46:4<458::AID-JBM3>3.0.CO;2-I ↗
72. Nanosurfaces modulate the mechanism of peri-implant endosseous healing by regulating neovascular morphogenesis10.1038/s42003-018-0074-y ↗
73. Towards cellular sieving: exploring the limits of scaffold accessibility for cell type specific invasion10.1002/adbi.201700257 ↗
74. Alginate: properties and biomedical applications10.1016/j.progpolymsci.2011.06.003 ↗
75. Alginate-based encapsulation of cells: past, present, and future10.1007/s11892-007-0051-1 ↗
76. Compliant 3D microenvironment improves beta-cell cluster insulin expression through mechanosensing and beta-catenin signaling10.1089/ten.tea.2013.0692 ↗
77. Hyaluronan content governs tissue stiffness in pancreatic islet inflammation10.1074/jbc.RA117.000148 ↗
78. Deformability-based microfluidic separation of pancreatic islets from exocrine acinar tissue for transplant applications10.1039/C7LC00890B ↗
79. Matrix stiffening in the formation of blood vessels
80. Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior10.1016/j.actbio.2012.08.007 ↗
81. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion10.1002/cm.20041 ↗
82. The role of substratum compliance of hydrogels on vascular endothelial cell behavior10.1016/j.biomaterials.2011.03.054 ↗
83. Cell-cell mechanical communication through compliant substrates10.1529/biophysj.107.127662 ↗
84. Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program10.1038/s41467-018-03959-6 ↗
85. Interaction of angiogenic microvessels with the extracellular matrix10.1152/ajpheart.00772.2007 ↗
86. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention10.1172/JCI6870 ↗
87. Matrix as an interstitial transport system10.1161/CIRCRESAHA.114.302335 ↗
88. Extracellular matrix-based materials for regenerative medicine10.1038/s41578-018-0023-x ↗
89. Therapeutic strategies for modulating the extracellular matrix to improve pancreatic islet function and survival after transplantation10.1007/s11892-018-1014-4 ↗
90. Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering10.1016/j.biomaterials.2013.05.066 ↗
91. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication10.1038/nm.3820 ↗
92. Islet beta cell mass in diabetes and how it relates to function, birth, and death10.1111/nyas.12031 ↗
93. Fibrin and wound healing10.1111/j.1749-6632.2001.tb03522.x ↗
94. Fibrin gels and their clinical and bioengineering applications10.1098/rsif.2008.0327 ↗
95. Characterization of integrin expression in islets isolated from hamster, canine, porcine, and human pancreas10.1177/002215549904700408 ↗
96. Significance of the peri-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig, and man10.1007/BF00318700 ↗
97. Young porcine endocrine pancreatic islets cultured in fibrin show improved resistance toward hydrogen peroxide10.4161/isl.26989 ↗
98. Bioengineering the endocrine pancreas: intraomental islet transplantation within a biologic resorbable scaffold10.2337/db15-1525 ↗
99. Bioengineering of an intraabdominal endocrine pancreas10.1056/NEJMc1613959 ↗
100. In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation10.1016/j.jconrel.2012.07.018 ↗